Recommended Conferences

PHYSIOTHERAPY 2022

Paris, France
Related Subjects
 

Physical activity is a predictor of all-cause mortality in patients with intermittent claudication

Author(s): Gardner AW, Montgomery PS, Parker DE

Abstract

Objective: We examined whether all-cause mortality was predicted by physical activity level in peripheral arterial disease (PAD) patients limited by intermittent claudication.

Methods: This retrospective, natural history follow-up study determined survival status of each patient. Patients with stable symptoms of intermittent claudication were evaluated in the Geriatrics, Research, Education, and Clinical Center at the Maryland Veterans Affairs Health Care System (MVAHCS) at Baltimore between 1994 and 2002, and were classified into a physically sedentary group (n = 299) or a physically active group (n =135), and followed in 2004 using the Social Security Death Index.

Results: Median follow-up was 5.33 years (range = 0.25 to 8.33 years) for the physically active group, and 5.0 years (range = 0.17 to 8.5 years) for the sedentary group. At follow-up, 108 patients (24.9%) had died, consisting of 86 (28.8%) in the sedentary group and 22 (16.3%) in the active group. Unadjusted risk of mortality was lower (P = .005) in the physically active group (hazard ratio [HR] = 0.510, 95% CI = 0.319 to 0.816). In multivariate Cox proportional hazards analysis, age (HR = 1.045, 95% CI = 1.019 to 1.072, P < 0.001), body mass index (BMI) (HR = 0.943, 95% CI = 0.902 to 0.986, P = 0.009), ankle-brachial index (ABI) (HR = 0.202, 95% CI = 0.064 to 0.632, p = 0.006), and physical activity status (HR = 0.595, 95% CI = 0.370 to 0.955, P = .031) were predictors of mortality.

Conclusion: Patients limited by intermittent claudication who engage in any amount of weekly physical activity beyond light intensity at baseline have a lower mortality rate than their sedentary counterparts who perform either no physical activity or only light-intensity activities. The protective effect of physical activity persists even after adjusting for other predictors of mortality, which include age, ABI, and BMI.

Similar Articles

Epidemiology of peripheral artery disease

Author(s): Criqui MH, Aboyans V

Mortality over a period of 10 years in patients with peripheral arterial disease

Author(s): Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, et al.

Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms

Author(s): McDermott MM, Liu K, Greenland P, Guralnik JM, Criqui MH, et al.

Health ABC Collaborative Research Group

Author(s): Newman AB, Haggerty CL, Kritchevsky SB, Nevitt MC, Simonsick EM

The long-term prognostic value of the resting and postexercise ankle-brachial index

Author(s): Feringa HH, Bax JJ, van Waning VH, Boersma E, Elhendy A, et al.

Heinz Nixdorf Recall Study Investigative Group

Author(s): Gronewold J, Hermann DM, Lehmann N, Kröger K, Lauterbach K, et al.

Physical activity during daily life and mortality in patients with peripheral arterial disease

Author(s): Garg PK, Tian L, Criqui MH, Liu K, Ferrucci L, et al.

Walking exercise in patients with intermittent claudication

Author(s): Bartelink ML, Stoffers HE, Biesheuvel CJ, Hoes AW

Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication

Author(s): Fokkenrood HJ, Bendermacher BL, Lauret GJ, Willigendael EM, Prins MH, et al.

Supervised vs unsupervised exercise for intermittent claudication: A systematic review and meta-analysis

Author(s): Vemulapalli S, Dolor RJ, Hasselblad V, Schmit K, Banks A, et al.

Supervised exercise therapy for intermittent claudication in daily practice

Author(s): Kruidenier LM, Nicolaï SP, Hendriks EJ, Bollen EC, Prins MH, et al.

Supervised exercise therapy for intermittent claudication in a community-based setting is as effective as clinic-based

Author(s): Bendermacher BL, Willigendael EM, Nicolaï SP, Kruidenier LM, Welten RJ, et al.

Experimental model of pain-free treadmill training in patients with claudication

Author(s): Mika P, Spodaryk K, Cencora A, Unnithan VB, Mika A